Purixan Interactions
There are 299 drugs known to interact with Purixan (mercaptopurine), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 60 are major, 224 are moderate, and 15 are minor.
- View all 299 medications that may interact with Purixan
- View Purixan alcohol/food interactions (1)
- View Purixan disease interactions (5)
Most frequently checked interactions
View interaction reports for Purixan (mercaptopurine) and the medicines listed below.
- Afinitor Disperz (everolimus)
- Afinitor Disperz (everolimus)
- Azilect (rasagiline)
- Azilect (rasagiline)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Cardizem CD (diltiazem)
- Cardizem CD (diltiazem)
- Copaxone (glatiramer)
- Copaxone (glatiramer)
- Corlanor (ivabradine)
- Corlanor (ivabradine)
- Coumadin (warfarin)
- Coumadin (warfarin)
- cyclophosphamide
- cyclophosphamide
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- Diacomit (stiripentol)
- Diacomit (stiripentol)
- Lasix (furosemide)
- Lasix (furosemide)
- methotrexate
- methotrexate
- Oncovin (vincristine)
- Oncovin (vincristine)
- prednisone
- prednisone
Purixan alcohol/food interactions
There is 1 alcohol/food interaction with Purixan (mercaptopurine).
Purixan disease interactions
There are 5 disease interactions with Purixan (mercaptopurine) which include:
More about Purixan (mercaptopurine)
- Purixan consumer information
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antimetabolites
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Blinatumomab
Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.